drug

pegcetacoplan

1 story · latest Oct 27, 2026

Follow pegcetacoplan. Every new filing, FDA action, and trial change, in your feed and a morning email, each linked to its source.

Follow free for 14 daysNo card.

Status: FDA approved May 2021 · NDA215014, NDA217171
Brands: Empaveli, Syfovre
Trials: 2 registered trials in coverage

Also known as

pegcetacoplan injection

Timeline

Artiva Biotherapeutics halts AlloNK development, cuts staff by 94%

Oct 27Quarterly updateArtiva Biotherapeutics, Inc.Biogen

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.